Cancer Treatment-Induced Osteoporosis with John Neustadt, ND
1.5 CE (.75 rx)
Learning Objectives:
Understand the risk for bone loss and osteoporosis with different cancers and medications
Understand osteoporosis screening guidelines in cancer patients.
Understand bone turnover markers (BTM) and their potential use with cancer patients.
Be comfortable discussing osteoporosis medications and understanding their potential benefits.
Be comfortable discussing integrative approaches to reducing fracture risk.
1.5 CE (.75 rx)
Learning Objectives:
Understand the risk for bone loss and osteoporosis with different cancers and medications
Understand osteoporosis screening guidelines in cancer patients.
Understand bone turnover markers (BTM) and their potential use with cancer patients.
Be comfortable discussing osteoporosis medications and understanding their potential benefits.
Be comfortable discussing integrative approaches to reducing fracture risk.
1.5 CE (.75 rx)
Learning Objectives:
Understand the risk for bone loss and osteoporosis with different cancers and medications
Understand osteoporosis screening guidelines in cancer patients.
Understand bone turnover markers (BTM) and their potential use with cancer patients.
Be comfortable discussing osteoporosis medications and understanding their potential benefits.
Be comfortable discussing integrative approaches to reducing fracture risk.